US20150011772A1 - Method for producing substituted anthranilic acid derivatives - Google Patents
Method for producing substituted anthranilic acid derivatives Download PDFInfo
- Publication number
- US20150011772A1 US20150011772A1 US14/375,496 US201314375496A US2015011772A1 US 20150011772 A1 US20150011772 A1 US 20150011772A1 US 201314375496 A US201314375496 A US 201314375496A US 2015011772 A1 US2015011772 A1 US 2015011772A1
- Authority
- US
- United States
- Prior art keywords
- chlorine
- alkyl
- fluorine
- formula
- identically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 [1*]C(=O)NC1=C([3*])C=CC=C1C([2*])=O.[4*]C Chemical compound [1*]C(=O)NC1=C([3*])C=CC=C1C([2*])=O.[4*]C 0.000 description 34
- TWOUFCUTXMWMBK-UHFFFAOYSA-N Cc(cc(cc1Br)C#N)c1NC(c1cc(C[n]2nnc(C(F)(F)F)n2)n[n]1-c(nccc1)c1Cl)=O Chemical compound Cc(cc(cc1Br)C#N)c1NC(c1cc(C[n]2nnc(C(F)(F)F)n2)n[n]1-c(nccc1)c1Cl)=O TWOUFCUTXMWMBK-UHFFFAOYSA-N 0.000 description 1
- KBUPJGPEIAZXDA-UHFFFAOYSA-N [H]N(C(=O)C1=CC(CN2N=NC(C(F)(F)F)=N2)=NN1C1=C(Cl)C=CC=N1)C1=C(C)C=C([N+]#[C-])C=C1Br Chemical compound [H]N(C(=O)C1=CC(CN2N=NC(C(F)(F)F)=N2)=NN1C1=C(Cl)C=CC=N1)C1=C(C)C=C([N+]#[C-])C=C1Br KBUPJGPEIAZXDA-UHFFFAOYSA-N 0.000 description 1
- ZXGHKCLTCMWQPQ-UHFFFAOYSA-N [H]N(C(=O)C1=CC(CN2N=NC(C(F)(F)F)=N2)=NN1C1=C(Cl)C=CC=N1)C1=C(C)C=C([N+]#[C-])C=C1C(=O)NC Chemical compound [H]N(C(=O)C1=CC(CN2N=NC(C(F)(F)F)=N2)=NN1C1=C(Cl)C=CC=N1)C1=C(C)C=C([N+]#[C-])C=C1C(=O)NC ZXGHKCLTCMWQPQ-UHFFFAOYSA-N 0.000 description 1
- OQRDGJGACGUFIZ-UHFFFAOYSA-N [H]N(C(=O)C1=CC(CN2N=NC(C(F)(F)F)=N2)=NN1C1=C(Cl)C=CC=N1)C1=C(C)C=C([N+]#[C-])C=C1C(=O)OC Chemical compound [H]N(C(=O)C1=CC(CN2N=NC(C(F)(F)F)=N2)=NN1C1=C(Cl)C=CC=N1)C1=C(C)C=C([N+]#[C-])C=C1C(=O)OC OQRDGJGACGUFIZ-UHFFFAOYSA-N 0.000 description 1
- PKUWMGJZQVKNBB-UHFFFAOYSA-N [H]N(C(C)=O)C1=C(C)C=C([N+]#[C-])C=C1C(=O)O Chemical compound [H]N(C(C)=O)C1=C(C)C=C([N+]#[C-])C=C1C(=O)O PKUWMGJZQVKNBB-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
Definitions
- the present invention relates to a novel process for preparing substituted anthranilic acid derivatives of the formula (I)
- R 1 , R 3 and R 4 radicals are each as defined above and
- R 6 and R 7 are each as defined above.
- substituted anthranilic acid derivatives of the formula (I) require the availability of the corresponding substituted anthranilic acid derivatives of the general formula (VII).
- substituted anthranilic acid derivatives of the general formula (VII) are either known or can be prepared by known organic chemistry methods. Some of these substituted anthranilic acid derivatives of the general formula (VII), however, can be prepared only in a complex manner, in multiple stages and at high cost, which can lead to uneconomically high costs for the end products as a result of unavoidable yield losses.
- Substituted anthranilic acid derivatives of the formula (I) are of high interest as compounds having known insecticidal efficacy (see, for example, Bioorg. & Med. Chem. Lett. 15 (2005) 4898-4906; Biorg. & Med. Chem. 16 (2008) 3163-3170). Further, it is already known, that substituted anthranilic acid derivatives of the general formula (VII) can be obtained by reacting substituted anthranilic acid derivatives of the general formula (IX) with carbon monoxide in the presence of a palladium catalyst, of a ligand, of a primary amine and a base (WO 2012/103436). However, it is not known whether anthranilic acid amides of the general formula (IV) can be used correspondingly.
- R 6 and R 7 are each as defined above to give the substituted anthranilic acid derivatives of the general formula (I).
- the present invention likewise provides novel compounds of the general formula (IV)
- R 1 , R 3 , R 4 and X radicals are each as defined above.
- Alkyl groups substituted by one or more fluorine or chlorine atoms are selected, for example, from trifluoromethyl (CF 3 ), difluoromethyl (CHF 2 ), CCl 3 , CFCl 2 , CF 3 CH 2 , ClCH 2 , CF 3 CCl 2 .
- Alkyl groups in the context of the present invention are linear or branched hydrocarbyl groups.
- alkyl and C 1 -C 12 -alkyl encompasses, for example, the meanings of methyl, ethyl, n-, isopropyl, n, iso-, sec- and t-butyl, n-pentyl, n-hexyl, 1,3-dimethylbutyl, 3,3-dimethylbutyl, n-heptyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl.
- Aryl radicals in the context of the present invention are aromatic hydrocarbyl radicals which may have one, two or more heteroatoms selected from O, N, P and S and may optionally be substituted by further groups.
- Alkylaryl groups (alkaryl groups) and alkylaryloxy groups in the context of the present invention are, respectively, aryl groups and aryloxy groups which are substituted by alkyl groups, may have a C 1-8 -alkylene chain and may have, in the aryl skeleton or aryloxy skeleton, one or more heteroatoms selected from O, N, P and S.
- Anthranilic acid derivatives of the formula (IV) can be prepared as follows:
- the reaction time may, according to the batch size and the temperature, be selected within a range between 1 hour and several hours.
- Process step 1 can optionally be performed in the presence of a catalyst.
- a catalyst examples include 4-dimethylaminopyridine or 1-hydroxybenzotriazole.
- the amount of palladium catalyst used in the process according to the invention is 0.001 to 20 mole percent, based on substituted anthranilic acid derivative of the general formula (IV) used. Preferably 0.005 to 10 mole percent is used, more preferably 0.01 to 5 mole percent.
- phosphine ligands include chelating bisphosphines. Examples of these include 1,2-bis(diphenylphosphino)ethane, 1,2-bis(diphenylphosphino)propane, 1,2-bis(diphenylphosphino)butane, 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl and 1,1′-bis(diphenylpho sphino)ferrocene.
- Preferred phosphine ligands are trialkylphosphines such as tri-tert-butylphosphine and triadamantylphosphine, and also triarylphosphines such as triphenylphosphine, tri(ortho-tolyl)phosphine or tri(para-methoxyphenyl)phosphine. Particular preference is given to triphenylphosphine.
- phosphine 1-20 molar equivalents of phosphine are used, based on the amount of palladium used. Preferably 2-15 molar equivalents are used.
- Process step 2 of the process according to the invention is performed in the presence of carbon monoxide (CO).
- CO carbon monoxide
- the carbon monoxide is typically introduced in gaseous form, and so the reaction is usually performed in an autoclave. It is customary to work at CO pressure 0.1 to 50 bar, preferably at 1 to 25 bar.
- carbon monoxide in the form of suitable metal carbonyl complexes, for example dicobalt octacarbonyl or molybdenum hexacarbonyl. Preference is given to working with gaseous carbon monoxide.
- Process step 2 is generally performed in the presence of a base.
- Suitable bases are organic bases such as trialkylamines, alkylpyridines, phosphazenes and 1,8-diazabicyclo[5.4.0]undecene (DBU).
- organic bases such as triethylamine, tripropylamine, tributylamine, diisopropylethylamine, pyridine, alkylpyridines, for example 2,6-dimethylpyridine, 2-methyl-5-ethylpyridine or 2,3-dimethylpyridine.
- the compounds of the general formula (V) or (VI) required for preparation of the substituted anthranilic acid derivatives of the general formula (I) are typically used in an excess, based on the substituted anthranilic acid derivative of the general formula (IV). It is also possible to use the compounds of the general formula (V) or (VI) in such an amount that they simultaneously serve as solvents.
- the autoclave After closure, the autoclave is purged with carbon monoxide and heated to 110° C., and a carbon monoxide pressure of 10 bar is maintained After 18 hours, the mixture is allowed to cool to room temperature, the autoclave is depressurized, the reaction mixture is stirred with methylene chloride and filtered through kieselguhr, and the filtrate is washed, first with dilute hydrochloric acid and then with water, dried over sodium sulphate and concentrated under reduced pressure. This gives 1.14 g of the title compound.
- the reaction mixture is stirred at room temperature for one hour and at 40° C. for 1 hour and cooled to room temperature, water and methylene chloride are added thereto, and the organic phase is removed, washed with dilute hydrochloric acid, dried and concentrated.
- the crude product thus obtained is purified by chromatography on silica gel (cyclohexane/ethyl acetate). This gives 1.30 g of the title compound as a pale beige solid.
- the autoclave After closure, the autoclave is purged with carbon monoxide and heated to 110° C., and a carbon monoxide pressure of 10 bar is maintained. After 18 hours, the mixture is allowed to cool to room temperature, the autoclave is depressurized, the reaction mixture is stirred with methylene chloride and filtered through kieselguhr, and the filtrate is washed, first with dilute hydrochloric acid and then with water, dried over sodium sulphate and concentrated under reduced pressure. This gives 0.49 g of the title compound.
- the autoclave After closure, the autoclave is purged with carbon monoxide and heated to 110° C., and a carbon monoxide pressure of 10 bar is maintained. After 18 hours, the mixture is allowed to cool to room temperature, the autoclave is depressurized, the reaction mixture is stirred with methylene chloride and filtered through kieselguhr, and the filtrate is washed, first with dilute hydrochloric acid and then with water, dried over sodium sulphate and concentrated under reduced pressure. This gives 0.475 g of the title compound.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12154290.6 | 2012-02-07 | ||
EP12154290 | 2012-02-07 | ||
PCT/EP2013/052350 WO2013117601A1 (de) | 2012-02-07 | 2013-02-06 | Verfahren zur herstellung von substituierten anthranilsäure-derivaten |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2013/052350 A-371-Of-International WO2013117601A1 (de) | 2012-02-07 | 2013-02-06 | Verfahren zur herstellung von substituierten anthranilsäure-derivaten |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/924,889 Continuation US9670182B2 (en) | 2012-02-07 | 2015-10-28 | Method for producing substituted anthranilic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150011772A1 true US20150011772A1 (en) | 2015-01-08 |
Family
ID=47722253
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/375,496 Abandoned US20150011772A1 (en) | 2012-02-07 | 2013-02-06 | Method for producing substituted anthranilic acid derivatives |
US14/924,889 Active US9670182B2 (en) | 2012-02-07 | 2015-10-28 | Method for producing substituted anthranilic acid derivatives |
US15/493,087 Expired - Fee Related US9969717B2 (en) | 2012-02-07 | 2017-04-20 | Method for producing substituted anthranilic acid derivatives |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/924,889 Active US9670182B2 (en) | 2012-02-07 | 2015-10-28 | Method for producing substituted anthranilic acid derivatives |
US15/493,087 Expired - Fee Related US9969717B2 (en) | 2012-02-07 | 2017-04-20 | Method for producing substituted anthranilic acid derivatives |
Country Status (10)
Country | Link |
---|---|
US (3) | US20150011772A1 (ja) |
EP (1) | EP2812310A1 (ja) |
JP (2) | JP2015511229A (ja) |
KR (1) | KR102032979B1 (ja) |
CN (2) | CN109970707A (ja) |
BR (1) | BR112014019487A2 (ja) |
IL (1) | IL233945A0 (ja) |
MX (1) | MX363730B (ja) |
TW (1) | TWI644888B (ja) |
WO (1) | WO2013117601A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI644888B (zh) * | 2012-02-07 | 2018-12-21 | 拜耳智慧財產有限公司 | 用於製備經取代之鄰胺苯甲酸衍生物之方法 |
WO2015162260A1 (en) * | 2014-04-25 | 2015-10-29 | Basf Se | Process for preparing anthranilamide esters and derivatives |
CN104961644B (zh) * | 2015-05-20 | 2017-04-12 | 上海交通大学 | 一种制备n‑芳基酰胺化合物的方法 |
CN106045870B (zh) * | 2016-07-07 | 2018-07-03 | 上海应用技术学院 | 一种制备酰胺的方法 |
CN109180518B (zh) * | 2018-10-18 | 2021-05-18 | 陕西科技大学 | 一种仲/叔酰胺类化合物及其合成方法 |
MX2023003173A (es) | 2020-09-17 | 2023-04-12 | Pi Industries Ltd | Un proceso para la sintesis de compuestos antranilicos de acido/amida e intermedios de los mismos. |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6635657B1 (en) * | 1998-12-23 | 2003-10-21 | Eli Lilly And Company | Aromatic amides |
US7456169B2 (en) * | 2003-02-27 | 2008-11-25 | Abbott Laboratories Inc. | Heterocyclic kinase inhibitors |
US7491718B2 (en) * | 2002-10-08 | 2009-02-17 | Abbott Laboratories | Sulfonamides having antiangiogenic and anticancer activity |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3161456D1 (en) * | 1980-02-06 | 1983-12-29 | Hoffmann La Roche | Process for the preparation of anthranilic acid derivatives |
US5739330A (en) * | 1996-02-05 | 1998-04-14 | Hoechst Celanese Corporation | Process for preparing quinazolones |
US6632815B2 (en) * | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
US6888004B2 (en) * | 2001-01-26 | 2005-05-03 | Bristol-Myers Squibb Company | Imidazolyl derivatives as corticotropin releasing factor inhibitors |
AR036872A1 (es) | 2001-08-13 | 2004-10-13 | Du Pont | Compuesto de antranilamida, composicion que lo comprende y metodo para controlar una plaga de invertebrados |
JP2004004374A (ja) | 2002-05-31 | 2004-01-08 | Canon Inc | 閃光撮影装置 |
BR0311707A (pt) * | 2002-06-13 | 2005-03-15 | Du Pont | Composto, composição e método de controle de pelo menos uma praga invertebrada |
JP2004043474A (ja) * | 2002-07-05 | 2004-02-12 | Nippon Nohyaku Co Ltd | 2−アミノ安息香酸誘導体及びその製造方法 |
US20040068012A1 (en) * | 2002-10-08 | 2004-04-08 | Comess Kenneth M. | Sulfonamides having antiangiogenic and anticancer activity |
PL209772B1 (pl) | 2003-01-28 | 2011-10-31 | Du Pont | Antraniloamidy, środek do zwalczania szkodnika będącego bezkręgowcem i sposób zwalczania szkodnika będącego bezkręgowcem |
TWI363756B (en) | 2004-12-07 | 2012-05-11 | Du Pont | Method for preparing n-phenylpyrazole-1-carboxamides |
DE102006032168A1 (de) * | 2006-06-13 | 2007-12-20 | Bayer Cropscience Ag | Anthranilsäurediamid-Derivate mit heteroaromatischen Substituenten |
UA99257C2 (ru) * | 2006-07-19 | 2012-08-10 | Е.І. Дю Пон Де Немур Енд Компані | Способ получения 3-замещенных 2-амино-5-галогенбензамидов |
TWI395728B (zh) | 2006-12-06 | 2013-05-11 | Du Pont | 製備2-胺基-5-氰基苯甲酸衍生物之方法 |
TWI415827B (zh) | 2006-12-21 | 2013-11-21 | Du Pont | 製備2-胺基-5-氰基苯甲酸衍生物之方法 |
TWI430980B (zh) | 2007-06-29 | 2014-03-21 | Du Pont | 製備2-胺基-5-氰基苯甲酸衍生物之方法 |
ATE538085T1 (de) | 2007-11-08 | 2012-01-15 | Du Pont | Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten |
TWI432421B (zh) | 2007-12-19 | 2014-04-01 | Du Pont | 製備2-胺基-5-氰基苯甲酸衍生物之方法 |
TWI431000B (zh) | 2008-03-05 | 2014-03-21 | Du Pont | 製備2-胺基-5-氰基苯甲酸衍生物之方法 |
KR20160148046A (ko) * | 2008-12-18 | 2016-12-23 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | 살해충제로서의 테트라졸 치환된 안트라닐산 아미드 |
EP2533641B1 (de) * | 2010-02-09 | 2016-07-13 | Bayer CropScience AG | Hydrazin-substituierte anthranilsäurederivate |
KR20130088127A (ko) * | 2010-06-15 | 2013-08-07 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | 신규 오르토-치환된 아릴 아미드 유도체 |
MX347841B (es) | 2010-06-15 | 2017-05-16 | Bayer Ip Gmbh | Procedimiento para preparar derivados de antranilamida sustituidos con tetrazoles y polimorfos cristalinos novedosos de estos derivados. |
EP2582695B1 (de) * | 2010-06-15 | 2015-09-30 | Bayer Intellectual Property GmbH | Anthranilsäurediamid-derivate mit zyklischen seitenketten |
EP2668153B1 (en) | 2011-01-28 | 2015-03-04 | E.I. Du Pont De Nemours And Company | Method for preparing 2-aminobenzamide derivatives |
TWI644888B (zh) * | 2012-02-07 | 2018-12-21 | 拜耳智慧財產有限公司 | 用於製備經取代之鄰胺苯甲酸衍生物之方法 |
-
2013
- 2013-02-06 TW TW102104496A patent/TWI644888B/zh not_active IP Right Cessation
- 2013-02-06 BR BR112014019487-4A patent/BR112014019487A2/pt not_active Application Discontinuation
- 2013-02-06 KR KR1020147024396A patent/KR102032979B1/ko active IP Right Grant
- 2013-02-06 US US14/375,496 patent/US20150011772A1/en not_active Abandoned
- 2013-02-06 EP EP13704756.9A patent/EP2812310A1/de not_active Withdrawn
- 2013-02-06 JP JP2014555260A patent/JP2015511229A/ja not_active Withdrawn
- 2013-02-06 CN CN201811620018.6A patent/CN109970707A/zh active Pending
- 2013-02-06 CN CN201380008403.4A patent/CN104245666B/zh not_active Expired - Fee Related
- 2013-02-06 WO PCT/EP2013/052350 patent/WO2013117601A1/de active Application Filing
- 2013-02-06 MX MX2014009317A patent/MX363730B/es active IP Right Grant
-
2014
- 2014-08-04 IL IL233945A patent/IL233945A0/en unknown
-
2015
- 2015-10-28 US US14/924,889 patent/US9670182B2/en active Active
-
2017
- 2017-04-20 US US15/493,087 patent/US9969717B2/en not_active Expired - Fee Related
- 2017-09-21 JP JP2017180910A patent/JP6438551B2/ja not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6635657B1 (en) * | 1998-12-23 | 2003-10-21 | Eli Lilly And Company | Aromatic amides |
US7491718B2 (en) * | 2002-10-08 | 2009-02-17 | Abbott Laboratories | Sulfonamides having antiangiogenic and anticancer activity |
US7456169B2 (en) * | 2003-02-27 | 2008-11-25 | Abbott Laboratories Inc. | Heterocyclic kinase inhibitors |
Non-Patent Citations (4)
Title |
---|
Fulford, e-EROS Encyclopedia of Reagents for Organic Synthesis (2001), John Wiley &Sons, Chichester, UK) CODEN:69KUHI * |
Seo et al. J. Org. Chem. 2006, 71, 8891-8900 * |
Sorgi et al. Encyclopedia of Reagents for Organic Synthesis, 2001, doi:10.1002/047084289X.rt164. * |
Valentine et al. Journal of Organic Chemistry, 1981, 46, 4614-4617. * |
Also Published As
Publication number | Publication date |
---|---|
CN104245666B (zh) | 2019-01-11 |
JP2015511229A (ja) | 2015-04-16 |
MX363730B (es) | 2019-04-01 |
MX2014009317A (es) | 2014-11-12 |
KR20140124810A (ko) | 2014-10-27 |
CN104245666A (zh) | 2014-12-24 |
US9670182B2 (en) | 2017-06-06 |
IL233945A0 (en) | 2014-09-30 |
BR112014019487A2 (pt) | 2020-10-27 |
US20170217934A1 (en) | 2017-08-03 |
JP6438551B2 (ja) | 2018-12-12 |
WO2013117601A1 (de) | 2013-08-15 |
US9969717B2 (en) | 2018-05-15 |
TWI644888B (zh) | 2018-12-21 |
JP2018027964A (ja) | 2018-02-22 |
EP2812310A1 (de) | 2014-12-17 |
TW201336811A (zh) | 2013-09-16 |
KR102032979B1 (ko) | 2019-10-16 |
CN109970707A (zh) | 2019-07-05 |
US20160046607A1 (en) | 2016-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9969717B2 (en) | Method for producing substituted anthranilic acid derivatives | |
US20110003999A1 (en) | Process for Preparing Substituted Biphenylanilides | |
JP5970065B2 (ja) | ピラゾール酸をアントラニル酸エステルと反応させる工程によってテトラゾール置換アントラニル酸ジアミド誘導体を製造する方法 | |
KR101949551B1 (ko) | 벤족사지논을 아민과 반응시켜 테트라졸-치환된 안트라닐산 디아미드 유도체를 제조하는 방법 | |
KR102167814B1 (ko) | 카복사미드 제조 방법 | |
KR101652360B1 (ko) | 치환된 비페닐아닐라이드의 제조방법 | |
JP5140776B1 (ja) | 1−置換−3−フルオロアルキルピラゾール−4−カルボン酸エステルの製造方法 | |
US9458091B2 (en) | Aromatic amidecarboxylic acid and process for producing the same | |
KR20160141788A (ko) | N-[3-(벤질카바모일)페닐]-1h-피라졸-5-카복사미드의 제조방법 | |
PL189843B1 (pl) | Sposób wytwarzania aryloamidów heteroaromatycznych kwasów karboksylowych | |
US9481650B2 (en) | Process for the preparation of 2-trifluoromethyl isonicotinic acid and esters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HIMMLER, THOMAS;PAZENOK, SERGII;VOLZ, FRANK;AND OTHERS;SIGNING DATES FROM 20140721 TO 20140725;REEL/FRAME:033476/0149 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |